Morgan Stanley
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
-
-
-
-
-
-
-
Zealand Pharma to participate in upcoming investor conferences
-
-
-
-
-
-
-
Morgan Stanley Resumes Zealand Pharma A/S (ZEAL) at Overweight
-
-
-
-
-
-
-
Overallotment option of 15% has been exercised
-
-
-
-
218,710 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

